Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Classement en actions #5446
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Prix de l'action
$90.29
Dernière synchronisation: 2026-08-26
Capitalisation boursière
$2.69B
Changement (1 jour)
3.30%
Changement (1 an)
-30.11%
Pays
US
Échange GeneDx Holdings Corp. (WGS)

Catégorie

Le prix WGS avec la capitalisation boursière de B
GeneDx Holdings Corp. GeneDx Holdings Corp.
WGS
$90.29
Capitalisation boursière de GeneDx Holdings Corp.(WGS)
Capitalisation boursière: $2.69B
En August 2026, GeneDx Holdings Corp. a une capitalisation boursière de $2.69B. Cela fait de GeneDx Holdings Corp. la 5446th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GeneDx Holdings Corp. du 2020 au 2026
WGS par rapport au top 5 des plus populaires stocks
Prix pour WGS L’actif B La capitalisation boursière de B Résultats
GeneDx Holdings Corp. GeneDx Holdings Corp.
$170,605 $2.69B
$5.088T +188,852.11%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$155,221 $2.69B
$4.629T +171,814.17%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$138,070 $2.69B
$4.118T +152,818.30%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$123,622 $2.69B
$3.687T +136,816.39%
GeneDx Holdings Corp. GeneDx Holdings Corp.
$93,876.87 $2.69B
$2.800T +103,872.61%